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1. BACKGROUND {#jonm12885-sec-0007}
=============

Nursing patient classification systems (PCS) have been employed in relation to nursing staff allocation efforts, budgeting, productivity and workload measurements.

Concepts related to PCS have been used interchangeably over time. Nursing workload refers to time and effort needed to accomplish both direct and indirect patient care, as well as nonpatient care activities (Swiger, Vance, & Patrician, [2016](#jonm12885-bib-0031){ref-type="ref"}); nursing intensity embeds direct and indirect patient‐related nursing care (Liljamo, Kinnunen, Ohtonen, & Saranto, [2017](#jonm12885-bib-0022){ref-type="ref"}), whilst patient acuity implies the categorization of patients based on their nursing care needs (Alghamdi, [2016](#jonm12885-bib-0005){ref-type="ref"}) to determine their required nursing intensity, in terms of nursing hours per patient day (NHPPD).

A widely used PCS is the *All Patient Refined Diagnosis‐related Groups* (APR‐DRGs) that cluster hospital discharged patients into groups of medical conditions and procedures, and subclassifies them into four categories of severity and risk of mortality, from low to extreme (Averill et al., [2003](#jonm12885-bib-0007){ref-type="ref"}); however, its usefulness to determine nursing care requirements or patient acuity remains unclear.

Regardless their design, either prototype---considering only selected relevant nursing tasks---or factor type---including a comprehensive list of nursing procedures---most of nursing PCS are based on interventions scores that may be explanatory of nursing workload, but they are not predictive of acuity or required nursing intensity according to the patient needs (Paulsen, [2018](#jonm12885-bib-0026){ref-type="ref"}). In addition, front‐line and head nurses perceive that workload is more influenced by patient characteristics, status or progress than by activity or tasks. Understanding patient status is essential in bedside decision‐making, and it includes data collection, cues capture, critical thinking and clinical judgment, considering the probable course of the patient (Manetti, [2019](#jonm12885-bib-0024){ref-type="ref"}). In this sense, the relationship between patient acuity and nurses\' clinical judgment is still underexplored.

Despite its conceptual ambiguity, clinical judgment is considered synonymous with decision‐making (Nibbelink & Brewer, [2018](#jonm12885-bib-0025){ref-type="ref"}) and for long, nurses\' clinical judgments on patient problems have been represented by nursing diagnoses (ND) (Juvé‐Udina, [2013](#jonm12885-bib-0019){ref-type="ref"}).

Recently, ND have been studied in relation to hospital length of stay using the NANDA International Classification (D\'Agostino et al., [2019](#jonm12885-bib-0012){ref-type="ref"}) or transfer to ICU and in‐hospital mortality employing the ATIC terminology (Juvé‐Udina et al., [2017](#jonm12885-bib-0020){ref-type="ref"}); however, existing PCS do not consider nurses\' clinical judgments on patient problems and their prioritization, although prioritizing impacts nursing workload (Swiger et al., [2016](#jonm12885-bib-0031){ref-type="ref"}).

In this context, bedside priority setting implies the arrangement of problems to set a preferential order guiding the provision of interventions, to meet the expected outcomes. Thus, prioritization of the patient problems should lead to the identification of a primary diagnosis and other secondary ones. In this sense, the main diagnosis embeds the clinical judgment on the patient problem that generates the greatest need of nursing care in terms of immediacy of its management, care intensity or complexity (Juvé‐Udina, [2013](#jonm12885-bib-0019){ref-type="ref"}).

Nevertheless, whilst the need to develop and implement new predictive models that allow real‐time measurements of patient acuity mix is stressed (Welton, [2017](#jonm12885-bib-0037){ref-type="ref"}), it is still unknown whether patient acuity could be predicted weighting their main problem (MP).

The primary aim of this study is to assess the ability of the patient main problem to predict acuity in adults admitted to hospital wards and step‐down units.

The secondary aims are to identify the distribution of acuity according to a PCS based on the MP weights and to evaluate whether differences exist in patient outcomes in terms of mortality, transfer to ICU, hospital readmission and three selected nursing‐sensitive adverse events: hospital‐acquired pressure injuries, falls and venous access‐associated phlebitis.

2. METHODS {#jonm12885-sec-0008}
==========

2.1. Design, setting and participants {#jonm12885-sec-0009}
-------------------------------------

This descriptive, observational, cross‐sectional, retrospective, multi‐centre study was conducted in 118 adult wards and 15 step‐down units, from eight public hospitals: three large, tertiary, metropolitan facilities (500--1,000 beds), three university hospitals (200--500 beds) and two community centres (100--200 beds). Average nurse per patient ratio in these floors is 1:10.5 (6--16) and 1:4 (3--6) in step‐down units.

Nurses in these facilities use the ATIC terminology (Appendix 1), employ the same electronic health record (EHR) system and share reason for admission‐based standardized care plans (SCP) that each nurse may adjust to the patient needs according to their assessment and judgment.

The study was intended to consecutively include the whole adult inpatient population admitted during 2016 and 2017. This represented a sample estimation of 200,000 patients. Critical care, maternal‐child and paediatric patients were excluded.

2.2. Data collection {#jonm12885-sec-0010}
--------------------

The institutional research ethics committee approved the study. Data were gleaned blinded according to the current European regulations on data protection. Ethical standards related to data confidentially (access to records, data encryption and archiving) were complied with throughout the research process (European Commission, [2018](#jonm12885-bib-0015){ref-type="ref"}).

Patients MP and outcomes data were blindly retrieved from the EHR. APR‐DRG severity and risk of mortality data were gleaned from the hospitals minimum data set. A consecutive ID number was assigned to each patient data set.

MP weights were calculated applying the formula $\sum{\lbrack(\%\,\text{severity})\,(\%\,\text{risk\ of\ mortality})\rbrack}$, considering all adults with the same MP identified in their care plan.

Mean weight variability of each MP was categorized in three groups: low (\<5%), moderate (5%--10%) and high (\>10%). To estimate the distribution of acuity, a PCS containing ten clusters, 40 subgroups and their equivalence to NHPPD was used (Appendix 2). The initial capacity of the MP weights to discriminate requirements of nursing intensity was categorized into excellent (\>90%), very good (80%--90%), good (70%--80%), sufficient (60%--70%), low (50%--60%) and not useful (\<50).

2.3. Data analysis {#jonm12885-sec-0011}
------------------

Descriptive statistics were employed to analyse sample characteristics, continuous variables and categorical data. Pearson\'s variation coefficient was used to estimate MP mean weight variability. Univariate analysis was used to assess MP initial discriminatory capacity, expressed in likelihood percentage.

To assess the ability of the MP weights to predict patient acuity, a logistic regression model was used. All potential explanatory variables included in the multivariate analyses were subjected to a correlation matrix for analysis collinearity. Results were reported as odds ratio (OR) at 95% confidence intervals (CI). The goodness of fit of the logistic model was evaluated by the Hosmer‐Lemeshow test, and the discriminatory power was assessed by the area under the receiver operating characteristics (ROC) curve.

Significant differences among nursing intensity clusters and patient outcomes were detected using the chi‐square test or Fisher\'s exact test for categorical variables. For continuous variables, Student\'s *t* test or Mann--Whitney *U* test was employed, depending on the results of the Kolmogorov‐Smirnov normality test. *p* values less than .05 were considered statistically significant. All reported *p* values are 2‐tailed.

The statistical analyses were performed using version 24.0 of SPSS package (IBM Chicago).

3. RESULTS {#jonm12885-sec-0012}
==========

The study considered 199,761 patients: 10,467 cases were excluded from the final analysis due to the absence of a care plan, no identification of the MP or not reaching 30 cases (5.2%), whereas 5,617 cases presented missed data or duplicates (2.8%).

The final analyses included 183,677 inpatients: 92.6% admitted in wards and 7.4% in step‐down units; 56.1% were male patients, and their mean age was 68.8 years. Average number of problems e‐charted in their care plans was 5.1 (range 2--11; 73% risk problems). The proportion of patients with minor or moderate APR‐DRG severity and risk of mortality was 76.3% and 82.3%, respectively (Table [1](#jonm12885-tbl-0001){ref-type="table"}).

###### 

Baseline sample characteristics

  Characteristic                                        Study population   
  ----------------------------------------------------- ------------------ --------
  Age ≥75 years                                         58,005             31.6
  Age (years)\_median (IQR)                             67                 53--78
  Male sex                                              102,764            55.9
  Medical ward                                          96,058             52.3
  Psychiatric ward                                      608                0.3
  Step‐down unit                                        13.582             7.4
  Unscheduled admission                                 101,749            55.4
  Length of stay_median (IQR)                           4                  2--8
  Continuity of care (discharged to another facility)   7,330              4.0
  Reason for admission                                                     
  Cardiocirculatory                                     30,336             16.5
  Infectious                                            27,208             14.8
  General surgery                                       20,766             11.3
  Trauma and orthopaedics                               19,951             10.8
  Digestive, liver and pancreatic                       19,790             10.7
  Nervous system                                        15,472             8.4
  Kidney and urinary tract                              13,959             7.6
  Respiratory                                           10,971             6.0
  Reproductive                                          8,257              4.5
  Head, neck and maxillofacial                          5,501              3.0
  Metabolic, nutritional and endocrinology              3,064              1.7
  Haematopoiesis, blood and immunologic                 2,705              1.5
  Psychiatric, mental health and addictions             1,192              0.6
  Skin and burns                                        907                0.5
  Eyes                                                  857                0.5
  Other                                                 2,741              1.5
  Severity (APR‐GRD 3--4)                               43,557             23.7
  Risk of mortality (APR‐GRD 3--4)                      32,558             17.7
  Severity or risk of mortality (APR‐GRD 3--4)          48,069             26.2

Abbreviations: IQR, interquartile range; APR‐DRG, all patient refined diagnosis‐related groups.
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3.1. Discriminatory ability of the main problem to predict acuity {#jonm12885-sec-0013}
-----------------------------------------------------------------

The 183,677 MP considered in the final analysis represent 77 primary diagnostic concepts. Their weights and correspondence to each acuity cluster are detailed in Table [2](#jonm12885-tbl-0002){ref-type="table"}. Most MP identified exhibit low or moderate mean weight variability (77.1%).

###### 

Main problems weights, variability and correspondence to acuity clusters

  Main problem                                                 *N*       Weight   *SD*    CI      PVC (%)   VAR        Acuity cluster
  ------------------------------------------------------------ --------- -------- ------- ------- --------- ---------- -----------------
  Post‐ICU syndrome                                            81        716      13.65   2.95    1.89      Low        Superintensive
  Risk of multiorgan failure                                   229       661      35.46   4.5     5.63      Moderate   Intensive
  Risk of organ graft rejection                                134       625      20.94   3.45    3.42      Low        Intensive
  Agony                                                        592       607      8.17    0.65    1.35      Low        Intensive
  Risk of cardiac tamponade                                    49        567      20.68   5.79    3.65      Low        Preintensive
  Risk of disuse syndrome                                      1,044     554      46.05   2.77    7.84      Moderate   Preintensive
  Risk of cardiogenic shock                                    330       549      4.87    0.51    0.88      Low        Preintensive
  Risk of neurotoxicity recurrence/progression                 205       540      52.89   7.1     9.05      Moderate   Preintensive
  Risk of ventricular arrhythmia                               51        538      6.08    1.65    1.13      Low        Preintensive
  Risk of respiratory distress                                 5,177     532      22.55   0.6     4.34      Low        Preintensive
  Risk of hepatorenal syndrome                                 602       524      27.7    2.18    5.17      Moderate   Preintensive
  Risk of encephalopathy recurrence/progression                511       520      12.3    1.05    2.36      Low        Preintensive
  Risk of cardiorenal syndrome                                 81        507      13.06   2.81    2.57      Low        Preintensive
  Risk of acute pulmonary oedema                               5,326     505      24.74   0.65    4.77      Low        Preintensive
  Risk of septic shock                                         1,950     500      33.75   1.47    6.44      Moderate   Intermediate
  Risk of thromboembolism                                      190       498      13.5    1.9     2.69      Low        Intermediate
  Risk of hypervolaemia                                        501       486      14.1    1.22    2.96      Low        Intermediate
  Risk of acidosis/alkalosis                                   1,354     484      29.3    1.54    5.84      Moderate   Intermediate
  Risk of acute deterioration                                  964       482      1.57    0.09    0.32      Low        Intermediate
  Risk of autonomic dysreflexia                                283       474      34.75   3.93    7.3       Moderate   Intermediate
  Risk of thromboembolism recurrence/progression               933       469      28.78   1.82    6.02      Moderate   Intermediate
  Risk of chest tamponade                                      600       463      7.88    0.62    1.7       Low        Intermediate
  Risk of neurogenic shock                                     48        455      36.16   9.73    7.94      Moderate   Intermediate
  Risk of sepsis                                               20,433    453      45.58   0.61    12.31     High       Intermediate
  Risk of cachectic syndrome recurrence/progression            112       450      8.83    1.61    1.96      Low        Intermediate
  Risk of uraemic syndrome                                     123       449      31.06   5.36    6.97      Moderate   Intermediate
  Risk of hypovolemic shock                                    610       447      19.04   1.41    4.24      Low        Intermediate
  Risk of delirium recurrence/progression                      476       439      19.14   1.68    4.37      Low        Intermediate
  Risk of brain vasospasm                                      600       437      15.36   1.21    3.5       Low        Intermediate
  Risk of hemodynamic instability                              589       436      1.77    0.14    0.41      Low        Intermediate
  Risk of alkalosis                                            215       424      6.13    0.81    1.44      Low        Intermediate
  Risk of hypoxaemia recurrence/progression                    1,426     421      25.6    1.3     5.97      Moderate   Intermediate
  Risk of brain ischaemia/haemorrhage recurrence/progression   6,621     418      37.18   0.88    8.11      Moderate   Intermediate
  Risk of hyper/hypovolaemia                                   897       417      45.8    2.96    10.28     High       Intermediate
  Risk of systemic inflammatory response syndrome              4,392     415      32.86   0.95    7.82      Moderate   Intermediate
  Risk of low cardiac output syndrome                          4,734     407      42.42   1.19    10.84     High       Intermediate
  Risk of hypovolaemia recurrence/progression                  2,280     404      24.32   0.98    5.9       Moderate   Intermediate
  Uncontrolled chronic pain                                    472       404      1.6     0.14    0.4       Low        Intermediate
  Risk of abdomen compartment syndrome                         351       394      25      2.57    6.3       Moderate   Intensification
  Risk of suicidal intentionality recurrence/progression       39        390      43.72   13.38   11.31     High       Intensification
  Risk of liver failure                                        1,376     389      39.79   2.07    10.35     High       Intensification
  Risk of multiorgan toxicity                                  542       382      16.66   1.31    4.35      Low        Intensification
  Risk of ischaemia recurrence/progression                     1,101     380      15.85   0.92    4.15      Low        Intensification
  Risk of hyperkalaemia                                        40        380      5.05    1.57    1.33      Low        Intensification
  Risk of effusion recurrence/progression                      565       373      21.94   1.75    5.9       Moderate   Intensification
  Risk of myocardial ischaemia recurrence/progression          7,205     371      2.56    0.05    0.69      Low        Intensification
  Risk of hypovolaemia                                         17,605    359      38.01   0.55    11.01     High       Intensification
  Risk of increased intracranial pressure                      3,495     343      41.11   1.34    11.13     High       Intensification
  Risk of biphasic anaphylaxis                                 33        336      9.72    3.18    2.89      Low        Intensification
  Risk of deliberated self‐harm                                194       335      1.14    0.15    0.34      Low        Intensification
  Risk of peritonitis                                          2,010     334      5.03    0.22    1.51      Low        Intensification
  Risk of neurological deterioration                           2,882     331      55.75   1.99    14.41     High       Intensification
  Risk of airway obstruction                                   209       330      53.73   7.22    15.15     High       Intensification
  Risk of ischaemia/haemorrhage                                3,114     324      30.15   1.04    8.88      Moderate   Intensification
  Risk of neurotoxicity                                        131       324      20.91   3.51    6.5       Moderate   Intensification
  Risk of myocardial ischaemia                                 1,297     323      8.33    0.44    2.58      Low        Intensification
  Risk of compartment syndrome                                 338       318      3.27    0.34    1.03      Low        Intensification
  Risk of effusion                                             199       318      2.34    0.33    0.73      Low        Intensification
  Risk of hypoxaemia                                           3,885     315      55.35   1.71    15.57     High       Intensification
  Risk of complicated functional recovery                      51        311      11.07   2.95    3.55      Low        Intensification
  Risk of hyper/hypoglycaemia                                  52        310      20.41   5.12    6.55      Moderate   Intensification
  Risk of haemorrhage recurrence/progression                   1,015     301      32.59   1.97    11.66     High       Intensification
  Risk of delusion recurrence/progression                      302       300      16.98   1.88    5.64      Moderate   Acute
  Risk of infection recurrence/progression                     5,155     299      39.35   1.05    13.29     High       Acute
  Risk of nutritional deficit recurrence/progression           59        298      2.28    0.58    0.76      Low        Acute
  Risk of pancreatitis                                         814       298      0.08    0.01    0.03      Low        Acute
  Risk of hyperadrenergic syndrome                             83        296      40.59   8.68    13.32     High       Acute
  Risk of sensory‐motor deficit                                840       292      18.95   1.26    6.34      Moderate   Acute
  Risk of arrhythmia recurrence/progression                    2,442     287      34.75   1.36    12.67     High       Acute
  Risk of anxiety‐depression syndrome                          515       283      7.91    0.67    2.76      Low        Acute
  Risk of haemorrhage                                          4,382     275      45.53   1.32    18.03     High       Acute
  Risk of decreased intracranial pressure                      218       269      13.74   1.8     5.15      Moderate   Acute
  Activity intolerance                                         81        258      27.32   5.8     10.61     High       Acute
  Risk of infection                                            913       257      32.15   2.03    11.84     High       Acute
  Risk of postoperative haemorrhage                            51,803    255      25.12   0.21    9.95      Moderate   Acute
  Risk of hypocalcaemia                                        1,113     243      5.55    0.32    2.28      Low        Acute
  Risk of postoperative infection                              2,013     235      14.47   0.62    6.15      Moderate   Acute
  TOTAL                                                        183,677                                                 

Abbreviations: *SD*, standard deviation; CI, 95% confidence interval; PVC, Pearson\'s variation coefficient; VAR, main problem mean weight variability.
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Univariate analysis showed 85.8% of the MP discriminate patients\' requirements of nursing care intensity higher than acute, with excellent (46.7%), very good (23.3%), good (11.6%) and sufficient (5.1%) capacity. Within the acute cluster, five MP initially displayed eventual discriminatory capacity (Table [3](#jonm12885-tbl-0003){ref-type="table"}).

###### 

Initial discriminatory capacity of the main problems

+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Main problem                                               | *N*    | \% patients APR‐DRG | \% Likelihood | Predictive capacity | Acuity          |
|                                                            |        |                     |               |                     |                 |
|                                                            |        | 3--4                |               |                     | cluster         |
+============================================================+========+=====================+===============+=====================+=================+
| Post‐ICU syndrome                                          | 81     | 97.53               | 99.85         | Excellent           | Superintensive  |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of multiorgan failure                                 | 229    | 90.39               | 99.36         | Excellent           | Intensive       |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of organ graft rejection                              | 134    | 85.07               | 98.94         | Excellent           | Intensive       |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Agony                                                      | 592    | 83.95               | 98.85         | Excellent           | Intensive       |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of ventricular arrhythmia                             | 51     | 82.35               | 98.71         | Excellent           | Preintensive    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of cardiac tamponade                                  | 49     | 79.59               | 98.46         | Excellent           | Preintensive    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of cardiogenic shock                                  | 330    | 77.88               | 98.30         | Excellent           | Preintensive    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of disuse syndrome                                    | 1,044  | 73.18               | 97.82         | Excellent           | Preintensive    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of respiratory distress                               | 5,177  | 72.51               | 97.75         | Excellent           | Preintensive    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of cardiorenal syndrome                               | 81     | 70.37               | 97.50         | Excellent           | Preintensive    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of neurotoxicity recurrence/progression               | 205    | 69.76               | 97.43         | Excellent           | Preintensive    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of hepatorenal syndrome                               | 602    | 69.27               | 97.37         | Excellent           | Preintensive    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of encephalopathy recurrence/progression              | 511    | 69.08               | 97.35         | Excellent           | Preintensive    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of acidosis/alkalosis                                 | 1,354  | 68.61               | 97.29         | Excellent           | Intermediate    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of hypervolaemia                                      | 501    | 67.07               | 97.10         | Excellent           | Intermediate    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of acute pulmonary oedema                             | 5,326  | 61.12               | 96.27         | Excellent           | Preintensive    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of autonomic dysreflexia                              | 283    | 60.42               | 96.17         | Excellent           | Intermediate    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of thromboembolism                                    | 190    | 60                  | 96.10         | Excellent           | Intermediate    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of septic shock                                       | 1,950  | 59.49               | 96.02         | Excellent           | Intermediate    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of haemodynamic instability                           | 589    | 56.37               | 95.50         | Excellent           | Intermediate    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of acute deterioration                                | 964    | 55.08               | 95.28         | Excellent           | Intermediate    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of neurogenic shock                                   | 48     | 54.17               | 95.11         | Excellent           | Intermediate    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of brain vasospasm                                    | 600    | 51.83               | 94.65         | Excellent           | Intermediate    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of chest tamponade                                    | 600    | 51.17               | 94.51         | Excellent           | Intermediate    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of thromboembolism recurrence/progression             | 933    | 50.38               | 94.35         | Excellent           | Intermediate    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of sepsis                                             | 20,433 | 49.14               | 94.08         | Excellent           | Intermediate    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of hypovolemic shock                                  | 610    | 48.03               | 93.83         | Excellent           | Intermediate    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of cachectic syndrome recurrence/progression          | 112    | 47.32               | 93.66         | Excellent           | Intermediate    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of hypoxaemia recurrence/progression                  | 1,426  | 46.42               | 93.44         | Excellent           | Intermediate    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of alkalosis                                          | 215    | 45.58               | 93.23         | Excellent           | Intermediate    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of uraemic syndrome                                   | 123    | 43.9                | 92.79         | Excellent           | Intermediate    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of systemic inflammatory response syndrome            | 4,392  | 40.78               | 91.88         | Excellent           | Intermediate    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of delirium recurrence/progression                    | 476    | 39.5                | 91.47         | Excellent           | Intermediate    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of hypovolaemia recurrence/progression                | 2,280  | 38.46               | 91.13         | Excellent           | Intermediate    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of hyper/hypovolaemia                                 | 897    | 35.56               | 90.08         | Excellent           | Intermediate    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Uncontrolled chronic pain                                  | 472    | 35.38               | 90            | Excellent           | Intermediate    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of abdomen compartment syndrome                       | 351    | 35.04               | 89.87         | Very good           | Intensification |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of effusion recurrence/progression                    | 565    | 33.45               | 89.21         | Very good           | Intensification |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of brain ischaemia/haemorrhage recurrence/progression | 6,621  | 33.26               | 89.12         | Very good           | Intermediate    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of low cardiac output syndrome                        | 4,734  | 32.81               | 88.93         | Very good           | Intermediate    |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of ischaemia recurrence/progression                   | 1,101  | 32.43               | 88.75         | Very good           | Intensification |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of liver failure                                      | 1,376  | 31.83               | 88.48         | Very good           | Intensification |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of suicidal intentionality recurrence/progression     | 39     | 30.77               | 87.97         | Very good           | Intensification |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of hypovolaemia                                       | 17,605 | 26.1                | 85.32         | Very good           | Intensification |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of increased intracranial pressure                    | 3,495  | 25.18               | 84.69         | Very good           | Intensification |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of airway obstruction                                 | 209    | 24.88               | 84.50         | Very good           | Intensification |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of myocardial ischaemia recurrence/progression        | 7,205  | 24.09               | 83.92         | Very good           | Intensification |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of deliberated self‐harm                              | 194    | 23.71               | 83.63         | Very good           | Intensification |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of hyperkalaemia                                      | 40     | 22.5                | 82.67         | Very good           | Intensification |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of complicated functional recovery                    | 51     | 21.57               | 81.88         | Very good           | Intensification |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of peritonitis                                        | 2,010  | 21.44               | 81.79         | Very good           | Intensification |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of biphasic anaphylaxis                               | 33     | 21.21               | 81.58         | Very good           | Intensification |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of neurological deterioration                         | 2,882  | 20.16               | 80.58         | Very good           | Intensification |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of neurotoxicity                                      | 131    | 19.85               | 80.28         | Very good           | Intensification |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of nutritional deficit recurrence/progression         | 59     | 15.25               | 77.19         | Good                | Acute           |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of compartment syndrome                               | 338    | 16.86               | 76.96         | Good                | Intensification |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of ischaemia/haemorrhage                              | 3,114  | 16.28               | 76.19         | Good                | Intensification |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of hyper/hypoglycaemia                                | 52     | 15.38               | 74.94         | Good                | Intensification |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of hypoxaemia                                         | 3,885  | 15.08               | 74.49         | Good                | Intensification |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of infection recurrence/progression                   | 5,155  | 13.39               | 74.39         | Good                | Acute           |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of myocardial ischaemia                               | 1,297  | 14.03               | 72.83         | Good                | Intensification |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of multiorgan toxicity                                | 542    | 13.47               | 71.91         | Good                | Intensification |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of effusion                                           | 199    | 13.07               | 71.18         | Good                | Intensification |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of haemorrhage recurrence/progression                 | 1,015  | 11.72               | 68.55         | Sufficient          | Intensification |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of hyperadrenergic syndrome                           | 83     | 9.64                | 66.73         | Sufficient          | Acute           |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of pancreatitis                                       | 814    | 9.21                | 65.61         | Sufficient          | Acute           |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of delusion recurrence/progression                    | 302    | 8.28                | 62.92         | Sufficient          | Acute           |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of haemorrhage                                        | 4,382  | 5.82                | 49.20         | Not useful          | Acute           |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of anxiety‐depression syndrome                        | 515    | 5.44                | 47.37         | Not useful          | Acute           |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of infection                                          | 913    | 5.15                | 45.95         | Not useful          | Acute           |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Activity intolerance                                       | 81     | 4.94                | 44.75         | Not useful          | Acute           |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of postoperative haemorrhage                          | 51,803 | 4.75                | 43.82         | Not useful          | Acute           |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of postoperative infection                            | 2,013  | 2.29                | 27.01         | Not useful          | Acute           |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of hypocalcaemia                                      | 1,113  | 1.53                | 19.35         | Not useful          | Acute           |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of sensory‐motor deficit                              | 840    | 13.21               | 19.22         | Not useful          | Acute           |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of arrhythmia recurrence/progression                  | 2,442  | 10.52               | 15.54         | Not useful          | Acute           |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+
| Risk of decreased intracranial pressure                    | 218    | 9.17                | 13.64         | Not useful          | Acute           |
+------------------------------------------------------------+--------+---------------------+---------------+---------------------+-----------------+

Abbreviations: APR‐DRG, all patient refined diagnosis‐related groups.
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A first multivariate analysis proved predictive ability of the MP in the intensification and upper clusters and confirmed that, four of those five MP that previously proved capacity exhibit sufficient predictive ability, suggesting they should be considered in the final model. The goodness of fit of this first model was 1, and the area under the ROC curve was 0.812 (95% CI, 0.809--0.815).

Final multivariate analysis findings indicated that there exists a strong association between the MP identified and nursing intensity requirements: their odds ratios are higher than 1, none of the 95% confidence intervals include 1 and most *p* values are \<.001 (Table [4](#jonm12885-tbl-0004){ref-type="table"}). No indication of collinearity between the variables that remained in the final model was found. The goodness of fit of the model was 1, and the area under the ROC curve was 0.814 (95% CI, 0.811--0.816) (Figure [1](#jonm12885-fig-0001){ref-type="fig"}).

###### 

Final multivariate analysis and correspondence with the acuity patient classification system

  Main problem                                                 *N*      OR       CI               p value   Acuity cluster                                            Weight                                        NHPPD   Range
  ------------------------------------------------------------ -------- -------- ---------------- --------- --------------------------------------------------------- --------------------------------------------- ------- ---------
  Post‐ICU syndrome                                            81       649.51   159.58--264.66   \<.001    Superintensive                                            716                                           14      14--23
  Risk of multiorgan failure                                   229      154.72   99.58--240.39    \<.001    Intensive                                                 661                                           12      10--13
  Risk of organ graft rejection                                134      93.73    58.22--150.90    \<.001    Intensive                                                 625                                           10      10--13
  Agony                                                        592      86.03    68.92--107.38    \<.001    Intensive                                                 607                                           10      10--13
  Risk of ventricular arrhythmia                               51       76.74    37.33--157.75    \<.001    Preintensive                                              538                                           8.25    7.5--10
  Risk of cardiac tamponade                                    49       64.13    31.99--128.55    \<.001    Preintensive                                              567                                           9       7.5--10
  Risk of cardiogenic shock                                    330      57.89    44.55--75.22     \<.001    Preintensive                                              549                                           8.25    7.5--10
  Risk of disuse syndrome                                      1,044    44.87    38.98--51.64     \<.001    Preintensive                                              554                                           9       7.5--10
  Risk of respiratory distress                                 5,177    43.38    40.50--46.47     \<.001    Preintensive                                              532                                           8.25    7.5--10
  Risk of cardiorenal syndrome                                 81       39.05    24.21--62.99     \<.001    Preintensive                                              507                                           7.5     7.5--10
  Risk of neurotoxicity recurrence/progression                 205      37.93    28.10--51.18     \<.001    Preintensive                                              540                                           8.25    7.5--10
  Risk of hepatorenal syndrome                                 602      37.06    31.08--44.20     \<.001    Preintensive                                              524                                           7.5     7.5--10
  Risk of encephalopathy recurrence/progression                511      36.74    30.37--44.44     \<.001    Preintensive                                              520                                           7.5     7.5--10
  Risk of acidosis/alkalosis                                   1,354    35.94    31.91--40.49     \<.001    Intermediate                                              484                                           7       5.5--7
  Risk of hypervolaemia                                        501      33.49    27.72--40.45     \<.001    Intermediate                                              486                                           7       5.5--7
  Risk of acute pulmonary oedema                               5,326    25.84    24.25--27.54     \<.001    Preintensive                                              505                                           7.5     7.5--10
  Risk of autonomic dysreflexia                                283      25.11    19.74--31.93     \<.001    Intermediate                                              474                                           6.5     5.5--7
  Risk of thromboembolism                                      190      24.67    18.42--33.03     \<.001    Intermediate                                              498                                           7       5.5--7
  Risk of septic shock                                         1,950    24.15    21.94--26.57     \<.001    Intermediate                                              500                                           7       5.5--7
  Risk of hemodynamic instability                              589      21.24    18.00--25.08     \<.001    Intermediate                                              436                                           6       5.5--7
  Risk of acute deterioration                                  964      20.17    17.69--22.98     \<.001    Intermediate                                              482                                           7       5.5--7
  Risk of neurogenic shock                                     48       19.43    11.01--34.32     \<.001    Intermediate                                              455                                           6.5     5.5--7
  Risk of brain vasospasm                                      600      17.7     15.03--20.83     \<.001    Intermediate                                              437                                           6       5.5--7
  Risk of chest tamponade                                      600      17.23    14.64--20.28     \<.001    Intermediate                                              463                                           6.5     5.5--7
  Risk of thromboembolism recurrence/progression               933      16.69    14.63--19.05     \<.001    Intermediate                                              469                                           6.5     5.5--7
  Risk of sepsis                                               20,433   15.89    15.24--16.57     \<.001    Intermediate                                              453                                           6.5     5.5--7
  Risk of hypovolemic shock                                    610      15.2     12.93--17.87     \<.001    Intermediate                                              447                                           6       5.5--7
  Risk of cachectic syndrome recurrence/progression            112      14.77    10.18--21.43     \<.001    Intermediate                                              450                                           6       5.5--7
  Risk of hypoxaemia recurrence/progression                    1,426    14.25    12.78--15.89     \<.001    Intermediate                                              421                                           5.5     5.5--7
  Risk of alkalosis                                            215      13.77    10.51--18.05     \<.001    Intermediate                                              424                                           5.5     5.5--7
  Risk of uraemic syndrome                                     123      12.87    9.00--18.40      \<.001    Intermediate                                              449                                           6       5.5--7
  Risk of systemic inflammatory response syndrome              4,392    11.32    10.58--12.12     \<.001    Intermediate                                              415                                           5.5     5.5--7
  Risk of delirium recurrence/progression                      476      10.73    8.91--12.93      \<.001    Intermediate                                              439                                           6       5.5--7
  Risk of hypovolaemia recurrence/progression                  2,280    10.28    9.39--11.25      \<.001    Intermediate                                              404                                           5.5     5.5--7
  Risk of hyper/hypovolaemia                                   897      9.08     7.89--10.44      \<.001    Intermediate                                              417                                           5.5     5.5--7
  Uncontrolled chronic pain                                    472      9        7.44--10.90      \<.001    Intermediate                                              404                                           5.5     5.5--7
  Risk of abdomen compartment syndrome                         351      8.87     7.11--11.07      \<.001    Intensification                                           394                                           5       3--5
  Risk of effusion recurrence/progression                      565      8.27     6.92--9.87       \<.001    Intensification                                           373                                           4.5     3--5
  Risk of brain ischaemia/haemorrhage recurrence/progression   6,621    8.19     7.72--8.70       \<.001    Intermediate                                              418                                           5.5     5.5--7
  Risk of low cardiac output syndrome                          4,734    8.03     7.50--8.60       \<.001    Intermediate                                              407                                           5.5     5.5--7
  Risk of peripheral ischaemia recurrence/progression          1,101    7.89     6.93--8.99       \<.001    Intensification                                           380                                           5       3.5--5
  Risk of liver failure                                        1,376    7.68     6.83--8.64       \<.001    Intensification                                           389                                           5       3.5--5
  Risk of suicidal intentionality recurrence/progression       39       7.31     3.70--14.44      \<.001    Intensification                                           390                                           5       3.5--5
  Risk of hypovolaemia                                         17,605   5.81     5.55--6.08       \<.001    Intensification                                           359                                           4.5     3.5--5
  Risk of increased intracranial pressure                      3,495    5.53     5.09--6.01       \<.001    Intensification                                           343                                           4       3.5--5
  Risk of airway obstruction                                   209      5.45     3.97--7.46       \<.001    Intensification                                           330                                           4       3.5--5
  Risk of myocardial ischaemia recurrence/progression          7,205    5.22     4.90--5.56       \<.001    Intensification                                           371                                           4.5     3.5--5
  Risk of deliberated self‐harm                                194      5.11     3.67--7.13       \<.001    Intensification                                           335                                           4       3.5--5
  Risk of hyperkalaemia                                        40       4.77     2.27--10.03      \<.001    Intensification                                           380                                           5       3.5--5
  Risk of complicated functional recovery                      51       4.52     2.32--8.82       \<.001    Intensification                                           335                                           4       3.5--5
  Risk of peritonitis                                          2,010    4.49     4.02--5.02       \<.001    Intensification                                           334                                           4       3.5--5
  Risk of biphasic anaphylaxis                                 33       4.43     1.92--10.21      \<.001    Intensification                                           336                                           4       3.5--5
  Risk of neurological deterioration                           2,882    4.15     3.77--4.57       \<.001    Intensification                                           331                                           4       3.5--5
  Risk of neurotoxicity                                        131      4.07     2.65--6.26       \<.001    Intensification                                           324                                           3.5     3.5--5
  Risk of compartment syndrome                                 338      3.34     2.51--4.44       \<.001    Intensification                                           318                                           3.5     3.5--5
  Risk of ischaemia/haemorrhage                                3,114    3.2      2.89--3.54       \<.001    Intensification                                           324                                           3.5     3.5--5
  Risk of hyper/hypoglycaemia                                  52       2.99     1.41--6.35       .004      Intensification                                           310                                           3.5     3.5--5
  Risk of hypoxaemia                                           3,885    2.92     2.66--3.21       \<.001    Intensification                                           315                                           3.5     3.5--5
  Risk of myocardial ischaemia                                 1,297    2.68     2.29--3.15       \<.001    Intensification                                           323                                           3.5     3.5--5
  Risk of multiorgan toxicity                                  542      2.56     2.00--3.28       \<.001    Intensification                                           382                                           5       3.5--5
  Risk of effusion                                             199      2.47     1.63--3.74       \<.001    Intensification                                           318                                           3.5     3.5--5
  Risk of haemorrhage recurrence/progression                   1,015    2.18     1.80--2.65       \<.001    Intensification                                           301                                           3.5     3.5--5
  Risk of delusion recurrence/progression                      302      1.69     1.12--2.55       .012      Intensification[b](#jonm12885-note-0007){ref-type="fn"}   301[a](#jonm12885-note-0006){ref-type="fn"}   3.5     3.5--5
  Risk of infection recurrence/progression                     5,155    2.90     2.66--3.17       \<.001    Intensification[b](#jonm12885-note-0007){ref-type="fn"}   301[a](#jonm12885-note-0006){ref-type="fn"}   3.5     3.5--5
  Risk of nutritional deficit recurrence/progression           59       3.38     1.66--6.88       .001      Intensification[b](#jonm12885-note-0007){ref-type="fn"}   301[a](#jonm12885-note-0006){ref-type="fn"}   3.5     3.5--5
  Risk of pancreatitis                                         814      1.90     1.50--2.42       \<.001    Intensification[b](#jonm12885-note-0007){ref-type="fn"}   301[a](#jonm12885-note-0006){ref-type="fn"}   3.5     3.5--5

The goodness of fit of the model was 1 and the area under the ROC curve was 0.814 (95% confidence interval 0.811--0.816).

Abbreviations: OR, odds ratio; CI, 95% confidence interval; NHPPD, nursing hours per patient day.

Final adjusted weight of the four MP initially located at the upper edge of the acute cluster that proved sufficient predictive ability.

Mean weight and intensity cluster adjusted according to univariate and initial multivariate analysis results.
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![ROC curve of the model on the ability of the main problem to predict patient acuity \[Colour figure can be viewed at <https://www.wileyonlinelibrary.com>\]\
*X*‐axis_specificity *Y*‐axis_sensitivity. Values: Goodness of fit of the model_1; Area under the ROC curve_0.814; Standard error_0.001; Asymptotic significance_0.000; 95% Confidence interval_0.811--0.816](JONM-27-1845-g001){#jonm12885-fig-0001}

3.2. Distribution of acuity {#jonm12885-sec-0014}
---------------------------

According to this model, 35.1% of the studied patients are classified in the acute cluster. Most patients fall into the intensification (29.4%) or intermediate (27.7%) categories, which are equivalent to 3.5--5 and 5.5--7 required NHPPD, respectively, whilst around 8% of patients need preintensive, intensive or superintensive care, corresponding to 7.5 to 14 required NHPPD (Table [5](#jonm12885-tbl-0005){ref-type="table"}). This implies that almost two thirds of the adult inpatient population (64.8%) need more intensive than acute nursing care, equivalent to an average required nursing intensity of 5.6 NHPPD or a 1:4.2 mean nurse per patient ratio. Similar values are found when excluding those patients in step‐down units. Considering only ward patients, 63.5% require more intensive than acute care: 7.7% preintensive, 25.5% intermediate, 29.8% intensification and 0.5% intensive or superintensive nursing care, whilst 36.5% are classified in the acute category.

###### 

Observed features and outcomes within each acuity cluster of the patient classification system

  Features and Outcomes                       Acute    Intensification                                   Intermediate   Preintensive                                      Intensive[a](#jonm12885-note-0009){ref-type="fn"}   Superintensive                                                                                                                                                           
  ------------------------------------------- -------- ------------------------------------------------- -------------- ------------------------------------------------- --------------------------------------------------- ------------------------------------------------- ------- ------------------------------------------------- ----- ------------------------------------------------- ---- -------------------------------------------------
  Clinical characteristics                                                                                                                                                                                                                                                                                                                                                                             
  Age (years). median (IQR)                   62       48--73[\*](#jonm12885-note-0010){ref-type="fn"}   66             52--77[\*](#jonm12885-note-0010){ref-type="fn"}   71                                                  58--81[\*](#jonm12885-note-0010){ref-type="fn"}   76      65--84[\*](#jonm12885-note-0010){ref-type="fn"}   65    54--77[\*](#jonm12885-note-0010){ref-type="fn"}   64   56--74
  Age ≥75 years                               13,400   20.8[\*](#jonm12885-note-0010){ref-type="fn"}     16,357         30.3[\*](#jonm12885-note-0010){ref-type="fn"}     20,458                                              40.3[\*](#jonm12885-note-0010){ref-type="fn"}     8,125   52.2[\*](#jonm12885-note-0010){ref-type="fn"}     105   28.9                                              16   19.8[\*\*](#jonm12885-note-0011){ref-type="fn"}
  Male sex                                    32,147   49.9[\*](#jonm12885-note-0010){ref-type="fn"}     32,885         60.8[\*](#jonm12885-note-0010){ref-type="fn"}     29,428                                              57.9[\*](#jonm12885-note-0010){ref-type="fn"}     7,752   58[\*](#jonm12885-note-0010){ref-type="fn"}       215   59.2                                              59   72.8[\*\*](#jonm12885-note-0011){ref-type="fn"}
  Severity or mortality risk (APR‐GRD 3--4)   3,256    5.1[\*](#jonm12885-note-0010){ref-type="fn"}      11,850         21.9[\*](#jonm12885-note-0010){ref-type="fn"}     22,985                                              45.2[\*](#jonm12885-note-0010){ref-type="fn"}     9,081   67.9[\*](#jonm12885-note-0010){ref-type="fn"}     321   88.4[\*](#jonm12885-note-0010){ref-type="fn"}     79   97.5[\*](#jonm12885-note-0010){ref-type="fn"}
  ICU admission                               1,267    2[\*](#jonm12885-note-0010){ref-type="fn"}        3,560          6.6[\*](#jonm12885-note-0010){ref-type="fn"}      4,985                                               9.8[\*](#jonm12885-note-0010){ref-type="fn"}      781     5.8                                               221   60.9[\*](#jonm12885-note-0010){ref-type="fn"}     66   81.5[\*](#jonm12885-note-0010){ref-type="fn"}
  LOS (days). median (IQR)                    2        1--4[\*](#jonm12885-note-0010){ref-type="fn"}     5              3--8[\*](#jonm12885-note-0010){ref-type="fn"}     7                                                   4--11[\*](#jonm12885-note-0010){ref-type="fn"}    7       5--12[\*](#jonm12885-note-0010){ref-type="fn"}    15    8--30[\*](#jonm12885-note-0010){ref-type="fn"}    62   33--90[\*](#jonm12885-note-0010){ref-type="fn"}
  Continuity of care (another facility)       1,539    2.4[\*](#jonm12885-note-0010){ref-type="fn"}      1,720          3.2[\*](#jonm12885-note-0010){ref-type="fn"}      3,300                                               6.5[\*](#jonm12885-note-0010){ref-type="fn"}      726     5.4[\*](#jonm12885-note-0010){ref-type="fn"}      26    7.2[\*\*](#jonm12885-note-0011){ref-type="fn"}    17   21[\*](#jonm12885-note-0010){ref-type="fn"}
  Outcomes                                                                                                                                                                                                                                                                                                                                                                                             
  Readmission (\<31 days)                     654      1[\*](#jonm12885-note-0010){ref-type="fn"}        2,497          4.6[\*](#jonm12885-note-0010){ref-type="fn"}      4,286                                               8.4[\*](#jonm12885-note-0010){ref-type="fn"}      1,491   11.1[\*](#jonm12885-note-0010){ref-type="fn"}     32    8.8[\*\*](#jonm12885-note-0011){ref-type="fn"}    1    1.2
  Transfer to ICU                             394      0.6[\*](#jonm12885-note-0010){ref-type="fn"}      842            1.6[\*](#jonm12885-note-0010){ref-type="fn"}      2,041                                               4[\*](#jonm12885-note-0010){ref-type="fn"}        201     1.3[\*](#jonm12885-note-0010){ref-type="fn"}      8     2.2                                               20   24.7[\*](#jonm12885-note-0010){ref-type="fn"}
  Adverse event                               1,932    3[\*](#jonm12885-note-0010){ref-type="fn"}        4,616          8.5[\*](#jonm12885-note-0010){ref-type="fn"}      6,526                                               12.8[\*](#jonm12885-note-0010){ref-type="fn"}     1,998   14.9[\*](#jonm12885-note-0010){ref-type="fn"}     61    16.8[\*](#jonm12885-note-0010){ref-type="fn"}     32   39.5[\*](#jonm12885-note-0010){ref-type="fn"}
  Phlebitis                                   1,527    2.4[\*](#jonm12885-note-0010){ref-type="fn"}      3,321          6.1[\*](#jonm12885-note-0010){ref-type="fn"}      3,913                                               7.7[\*](#jonm12885-note-0010){ref-type="fn"}      1,018   7.6[\*](#jonm12885-note-0010){ref-type="fn"}      32    8.8[\*\*](#jonm12885-note-0011){ref-type="fn"}    11   13.6[\*\*](#jonm12885-note-0011){ref-type="fn"}
  Pressure ulcer                              160      0.2[\*](#jonm12885-note-0010){ref-type="fn"}      378            0.7[\*](#jonm12885-note-0010){ref-type="fn"}      814                                                 1.6[\*](#jonm12885-note-0010){ref-type="fn"}      284     2.1[\*](#jonm12885-note-0010){ref-type="fn"}      12    3.3[\*](#jonm12885-note-0010){ref-type="fn"}      21   25.9[\*](#jonm12885-note-0010){ref-type="fn"}
  Falls                                       173      0.3[\*](#jonm12885-note-0010){ref-type="fn"}      336            0.6[\*](#jonm12885-note-0010){ref-type="fn"}      557                                                 1.1[\*](#jonm12885-note-0010){ref-type="fn"}      144     1.1[\*](#jonm12885-note-0010){ref-type="fn"}      2     0.6                                               4    4.9[\*\*](#jonm12885-note-0011){ref-type="fn"}
  Deceased                                    150      0.2[\*](#jonm12885-note-0010){ref-type="fn"}      811            1.5[\*](#jonm12885-note-0010){ref-type="fn"}      1,695                                               3.3[\*](#jonm12885-note-0010){ref-type="fn"}      734     5.5[\*](#jonm12885-note-0010){ref-type="fn"}      21    5.8[\*](#jonm12885-note-0010){ref-type="fn"}      8    9.9[\*](#jonm12885-note-0010){ref-type="fn"}

Abbreviations: IQR, interquartile range; APR‐GRD, all patient refined diagnosis‐related group; ICU, intensive care unit; LOS, length of stay

Excluded those patients with *Agony* as the main problem for its relationship with mortality and other outcomes.

*p* value \<0.001 (categorical variables were compared using the Fisher exact test and continuous variables using the Mann--Whitney test)

*p* value \>0.001 and \<0.05 (categorical variables were compared using the Fisher exact test and continuous variables using the Mann--Whitney test)
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3.3. Patient outcomes {#jonm12885-sec-0015}
---------------------

Observed patient outcomes show statistically significant differences among the acuity clusters in terms of adverse events, hospital readmission, transfer to ICU and mortality (*p* \< .005). In comparison with the acute group, outcome values are twofold to fivefold in the intensification category and most values almost twist again for intermediate care acuity group (Table [5](#jonm12885-tbl-0005){ref-type="table"}). Adverse events display increasing trends in the upper clusters, whilst transfer to ICU decreases, except for those individuals in the superintensive group. When compared to patients classified as requiring acute intensity (0.2%), mortality increases sevenfold within the intensification cluster (1.5%), and up to 3.3% and 5.5% in the intermediate and preintensive categories, respectively (Table [5](#jonm12885-tbl-0005){ref-type="table"}).

4. DISCUSSION {#jonm12885-sec-0016}
=============

4.1. Discussion of the results {#jonm12885-sec-0017}
------------------------------

The primary finding of this study is that the MP are independent predictors of patient acuity. The area under the ROC curve (AUC) indicates a remarkable ability of the MP weight model to determine acuity, with an 81% chance to distinguish required nursing intensity among patients admitted in wards and step‐down units. Acuity distribution shows most inpatients match acuity clusters higher than acute, and their outcomes in terms of nurse‐sensitive outcomes worsen as acuity increases.

In the absence of similar studies, the result from a recent inquiry on the ability of the Oulu PCS scores and nursing notes to predict acuity was used for comparison (Kontio et al., [2014](#jonm12885-bib-0021){ref-type="ref"}). Their model achieved a concordance index of 0.821 that may be interpreted as a refined AUC value, consistent with our findings.

Likewise, a recent systematic review identifies the need for refining workload measurements based on "*weighted patients according to their care loads*" (Wynendaele, Willems, & Trybou, [2019](#jonm12885-bib-0038){ref-type="ref"}). In this study, the MP weights seem to be clinically meaningful, ranking problems such as post‐ICU syndrome or risk of multiorgan failure first. This could suggest that the higher the medical intricacy, the greater the nursing intensity required; however, other MP at the top of the ranking dispel this misconception. This is the case for instance of patients diagnosed with agony, the struggle that precedes death in those states in which life is gradually extinguished. Intensive palliative care has been identified for ward patients at risk for dying soon who experience severe symptoms, reporting an average of 10.3 NHPPD (Fuly, Pires, Souza, Oliveira, & Padilha, [2016](#jonm12885-bib-0016){ref-type="ref"}).

Regarding mental health MP, none is found within upper acuity groups. In the psychiatric population, factors, such as entrapment, history of self‐harm or maladaptive personality traits, may play a role in acuity assessment. The need for further research in this area has recently been reported (Sousa & Seabra, [2018](#jonm12885-bib-0029){ref-type="ref"}). Similarly, psycho‐emotional and mental health impairments have been described as individual complexity sources (Adamuz et al., [2018](#jonm12885-bib-0001){ref-type="ref"}), calling for deepening studies on the relationship between acuity and complexity.

According to the findings, 64.8% of the adult inpatient population needs more intensive than acute nursing care, with an average required nursing care intensity of 5.6 NHPPD. This finding aligns with nursing intensity identified in the study on staffing and mortality by Aiken et al. ([2017](#jonm12885-bib-0004){ref-type="ref"}), and are quite consistent with the allocation of an average NHPPD "*ranging from 3.5 to 7.5*" (Twigg & Duffield, [2009](#jonm12885-bib-0034){ref-type="ref"}). The findings also positively contrast with the results of several studies measuring workload that reported a mean of six to twelve NHPPD in different hospital wards (Silva et al., [2015](#jonm12885-bib-0027){ref-type="ref"}; Trepichio, Guirardello Ede, Duran, & Brito, [2013](#jonm12885-bib-0033){ref-type="ref"}). Other inquiries concluded that workload in step‐down units was similar to conventional ICUs (Amstrong et al., [2015](#jonm12885-bib-0006){ref-type="ref"}; D\'Orazio, Dragonetti, Finiguerra, & Simone, [2015](#jonm12885-bib-0014){ref-type="ref"}).

Conversely, information volume has been assessed as a measure of care intensity. The relationship on the number of nursing notes and acuity has been explored (Liljamo, Kinnuen, & Saranto, [2018](#jonm12885-bib-0023){ref-type="ref"}), and the number of ND has been analysed related to needed nursing intensity (Castellan, Sluga, Spina, & Sanson, [2016](#jonm12885-bib-0010){ref-type="ref"}); however, a high number of ND might be reflecting poor prioritization and a linear decision‐making process, in which each problem seems to be conceived independent from the others and the whole situation of the patient.

Nurses\' priority setting of patient problems is based on urgency, clinical significance, potential harm, impact in daily living and patient perceptions of importance, but prioritization also depends on clinical expertise of registered nurses, time constraints, budget balance, professional values and organizational context (Skirbekk, Hem, & Nortvedt, [2018](#jonm12885-bib-0028){ref-type="ref"}; Vryonides, Papastavrou, Charalambous, Androu, & Merkouris, [2015](#jonm12885-bib-0036){ref-type="ref"}). In this sense, positive practice environments enhance nurse expertise to deliver high‐quality nursing care and influence their decision‐making and priority setting. Nurses\' clinical judgments and patients care plans, essential concepts in this study, are factors considered in the evaluation of practice environments when using the Practice Environment Scale of the Nursing Work Index (Swiger et al., [2017](#jonm12885-bib-0030){ref-type="ref"}).

In the context of this inquiry, reason for admission, population‐based SCP are used to assure patient care quality and safety, and to ease nursing care provision and documentation. Population‐based care models are oriented at improving health outcomes of different groups of individuals, and their approach emphasizes prevention and intervention at different echelons, implying the patient exists from the individual and family level, as groups or communities, to populations in themselves (Iseel & Bekemeier, [2010](#jonm12885-bib-0018){ref-type="ref"}). Likewise, population‐based SCP are a form of nursing structural capital, since they are knowledge shifted into information structures that nurses employ to support their clinical decision‐making and planning (Covell & Sidani, [2013](#jonm12885-bib-0011){ref-type="ref"}). The use of SCP could be considered a weakness, since it might influence the prioritization of the MP; however, nurses using them in practice may change any aspect of their content, to adjust SCP to each patient needs based on assessment data analysis (Castellà‐Creus, Delgado‐Hito, Andrés‐Martinez, & Juvé‐Udina, [2019](#jonm12885-bib-0009){ref-type="ref"}). In fact, it is known that nurses\' experience and their understanding of the patient status influence the use of SCP. Experienced nurses tend to favour their own expertise over information contained in a standard to guide their decision‐making and properly individualize the SCP to the patient status and needs (Nibbelink & Brewer, [2018](#jonm12885-bib-0025){ref-type="ref"}).

4.2. Strengths and limitations {#jonm12885-sec-0018}
------------------------------

To the best of our knowledge, this is the first acuity PCS based on nurses\' clinical judgment on patient problems and their prioritization.

The study presents those limitations implicitly embedded in a retrospective, cross‐sectional, limited to a national level inquiry, whilst its multi‐centre approach and large sample size are remarkable strengths.

Mean weight variability of the MP was low or moderate in most instances; however, in the absence of similar studies, the categorization of the PVC was just based on the authors\' consensus. High mean heft variability could be related to nurses\' limited knowledge on a selected problem screening or identification (i.e. risk of suicidal intentionality recurrence/progression) or difficulties identifying problems at the borderlines between two or more established entities (i.e. differentiation between risk of infection recurrence/progression from risk of sepsis), so further studies are needed to gain a better understanding on this issue since, as long as there exist multiple levels of nurses\' clinical expertise, different degrees of situation awareness capacity and clinical judgment accuracy will co‐exist (Nibbelink & Brewer, [2018](#jonm12885-bib-0025){ref-type="ref"}).

In this study, the effect of patient secondary problems and individual complexity factors (Adamuz et al., [2018](#jonm12885-bib-0001){ref-type="ref"}) were not controlled. To what extent these variables influence acuity at individual level is unknown, so additional studies are granted. In addition, because of its cross‐sectional design, changes in patient status could not be considered. Nevertheless, the findings are consistent with the results of a longitudinal inquiry on patient acuity, based on nurses\' clinical judgment that identified a subset of heart failure inpatients classified as requiring higher levels of nursing intensity in terms of NHPPD (Garcia, [2017](#jonm12885-bib-0017){ref-type="ref"}).

On the other hand, in this investigation, patient outcomes in each acuity group were only analysed for observational purposes, so causal relationships cannot be proven. The findings indicate significant differences on major outcomes among the acuity clusters, suggesting a potential association that has to be demonstrated. Most outcomes p values are statistically significant, but it is acknowledged that p values are dependent on the sample size, so these findings should be interpreted with caution.

Additionally, the terminology used by nurses in this study is not as renowned as other nursing language systems, but it offers conceptual coverage for multiple cascade effect problems and for different types of nurses\' clinical judgments (Juvé‐Udina, [2013](#jonm12885-bib-0019){ref-type="ref"}).

Thompson, Aitken, Doran, and Dowding ([2013](#jonm12885-bib-0032){ref-type="ref"}) classified four types of clinical judgments: those statements describing causality, the actually descriptive, the ones which are evaluative, considering changes in status from one point in time to another, and those predicting the likely course of a patient.

The results of our study suggest that only a few MP identified by nurses are descriptive. Most of them (94%) are risk problems that match predictive or combined type clinical judgments, such as risk of hemodynamic instability (predictive), risk of disuse syndrome (causal and predictive) or risk of peripheral ischaemia recurrence/progression (evaluative and predictive). These types of judgments arise from the combination of several sources of information, with initial and ongoing assessment data being pivotal. In this sense, the results of the present inquiry correspond almost inversely with the ones in a study on prevalent ND in the hospital ward setting using the NANDA‐I Classification (D\'Agostino et al., [2017](#jonm12885-bib-0013){ref-type="ref"}), where most of them are actual, descriptive judgments, and only 15% are predictive. To some extent, this might suggest the influence of each language system used to represent nurses\' clinical judgments on patient problems in the EHR.

4.3. Implications for nursing management {#jonm12885-sec-0019}
----------------------------------------

A major objective for nurse managers is to strike the balance among nursing care quality, patient safety, practice environment, nursing workload and expenditure. Lack of consideration of patient problem prioritization is one of the factors that may impact quality, safety and workload measurement (Swiger et al., [2016](#jonm12885-bib-0031){ref-type="ref"}).

Prioritization of nurses\' clinical judgments is essential to identify relationships among problems and avoid severe consequences for patients. All patient needs should be considered, but addressing the MP may contribute to prevent or solve other secondary ones. This implies prioritizing problems contributing, causing or triggering other ones, mostly according to the severity of the patient conditions and their risk of death, both variables considered in the MP weights model presented, found to be predictive of acuity. Moreover, our results coincide to existing evidence on the identification of hospital wards no longer as conventional units, but areas with multiple patient acuity profiles, from acute to superintensive.

The PCS presented does not require the nurse to complete any additional data form to inform patient acuity, since the MP weights can be included as a field in the corresponding database table in any EHR system, for subsequent data mining, exploitation, use or reuse. Moreover, in terms of nursing international data exchange, comparison or benchmarking, given the different nursing and healthcare language systems used in the EHR around the world, concept mappings among terminologies could be employed to minimize the eventual gaps in acuity measurement (Bowles et al., [2013](#jonm12885-bib-0008){ref-type="ref"}).

Although in this study patient acuity was not confronted to nursing intensity offered, the average nurse per patient ratio in this inquiry (1:10.5) is slightly lighter than the national ratio (1:12.9) and heavier than the European (1:9), according to the data reported in an international cross‐sectional survey (Aiken et al., [2012](#jonm12885-bib-0002){ref-type="ref"}). This might suggest a relevant implication for nursing and healthcare management, ethics and politics, since almost two thirds of adult inpatients might not be receiving the nursing care intensity they need. Nevertheless, further research is needed since average nurse per patient ratio methods may be useful to inform workload at aggregated level but they may result insufficient at unit and individual level (Paulsen, [2018](#jonm12885-bib-0026){ref-type="ref"}; Welton, [2017](#jonm12885-bib-0037){ref-type="ref"}).

Finally, the subservient position of nurses has been identified as the "*root cause of nurse staffing problems*" (van Oostveen, Mathijssen, & Vermeulen, [2015](#jonm12885-bib-0035){ref-type="ref"}); however, it has been demonstrated that promoting favourable work environments is reasonably low‐cost, creating added value for better patient outcomes (Aiken et al., [2018](#jonm12885-bib-0003){ref-type="ref"}). The use of PCS based on nurses\' clinical judgments may contribute to enhance professional autonomy and to promote less task‐oriented and more patient‐centred, supportive practice environments. Acknowledging its limitations, the PCS presented exhibits capacity to prospectively inform patient acuity, support workforce planning and staffing decision‐making at hospital or unit level, estimate nursing costs and contribute to optimize patients, nurses and organizational outcomes.

5. CONCLUSION {#jonm12885-sec-0020}
=============

The patient main problem predicts patient acuity, suggesting this PCS is a useful tool to estimate nursing time requirements of adult patients admitted to hospital wards and step‐down units.

The majority of adult ward inpatients are in need for more intensive than acute nursing care, and their outcomes in terms of mortality, transfer to ICU, hospital readmission, falls, pressure injuries and catheter‐associated phlebitis are observed to be adversely affected, advancing that they are probably not receiving the nursing intensity required.
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